Ming Chen, MD
Ophthalmology Physician in Honolulu, Hawaii.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,388 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Ming Chen, MD filed 3,576 Medicare Part D claims in 2024 as an Ophthalmology Physician in Honolulu, Hawaii, prescribing 44% generic.
- 4K
- Part D claims, 2024
- 44%
- generic prescribing
- $2.7K
- industry payments (Sunshine Act)
- ≥90th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Ming Chen, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1376621318), first enumerated 11/01/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,576 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$2.7K in reported industry payments (32 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1376621318 · Ophthalmology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1376621318
- ENUM-LEGACY 2006
- TAX-MID 22K Ophthalmology Physician
- RX-MID 3,576
- BOOK-THIN 128 in Hawaii
- PHOTO-ENUM Gustavo Hernandez, M… · 2006
Ming Chen, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
3,576 ≥ 90th percentile 90% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Ming Chen, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ming Chen, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Hawaii
How Ophthalmology Physician compares to other specialties among Hawaii providers
Ophthalmology Physician ranks #43 among Hawaii's specialties (0.4% of in-state providers)
Each bar is a specialty's share of the Hawaii provider total, by primary NUCC taxonomy. The highlighted bar is Ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ophthalmology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1376621318 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 11/01/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Ming Chen, MD's current license status, disciplinary history, and board certifications with the Hawaii Medical Board in Hawaii before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1376621318 is the unique 10-digit identifier CMS uses to link Chen across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ming Chen, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.7K
Largest payer
Bausch & Lomb Americas Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
56% brand-name claims vs 44% generic, on 3,576 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 5,591.267
- Total Day Supply
- 154,115
- Brand vs Generic
- 56% brand / 44% generic
- Brand Drug Cost
- $1.0M
- Generic Drug Cost
- $61K
Patient Demographics
- Average Patient Age
- 77.5 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Ming Chen, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Restasis
Restasis
653 claims
- Erythromycin
Erythromycin
547 claims
- Latanoprost
Latanoprost
537 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
280 claims
- Timolol Maleate 194
Timolol Maleate
194 claims
- Xiidra 136
Xiidra
136 claims
- Dorzolamide-Timolol 121
Dorzolamide-Timolol
121 claims
- Lumigan 119
Lumigan
119 claims
| Drug | Claims |
|---|---|
| Restasis Cyclosporine | 653 |
| Erythromycin Erythromycin Base | 547 |
| Latanoprost | 537 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 280 |
| Timolol Maleate | 194 |
| Xiidra Lifitegrast | 136 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 121 |
| Lumigan Bimatoprost | 119 |
| Prednisolone Acetate | 117 |
| Ofloxacin | 102 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Ming Chen, MD fits within the Ophthalmology Physician landscape nationally.
Ming Chen, MD's 3,576 claims are above the specialty average of 1,490.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Chen, both outside Hawaii so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in Hawaii
Other clinicians with the same primary specialty enrolled in Hawaii, drawn from the same CMS NPPES roster as Chen.
One of 128 Ophthalmology Physician providers enrolled in Hawaii, 5 are shown here.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ming Chen, MD's specialty? ▼
How much does Ming Chen, MD prescribe under Medicare Part D? ▼
Where is Ming Chen, MD located? ▼
What is Ming Chen, MD's NPI number? ▼
Does Ming Chen, MD prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does Ming Chen, MD prescribe most often? ▼
Does Ming Chen, MD accept Medicare? ▼
How can I verify Ming Chen, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.